Proceedings from a live event on May 31, 2026, held during the 2026 ASCO Annual Meeting and moderated by Dr Jeremy S Abramson. Published August 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 2.25 credits
MOC types
ABIM — Medical KnowledgeUp to 2.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 2.25 credits
- MOC · Up to 2.25 points
-
ReleasedAug 13, 2026
-
Last day to claim creditAug 15, 2027 10 months left
-
American Society of Clinical Oncology Management of Bispecific Antibody Toxicities – 2026 ASCO Annual Meeting
-
United States Myeloma Innovations Research Collaborative +1 National ICE-T Conference –Orlando, FL, 2026
-
HealthTree Foundation for Non-Hodgkin Lymphoma +1 Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond
-
Research to Practice Cases from the Community: Investigators Discuss the Optimal Management of Chronic Lymphocytic Leukemia (Symposium Proceedings)
-
Research to Practice Practical Perspectives on the Current Role of Bispecific Antibodies in the Management of Lymphoma What Happened at ASH 2025? | 2026 (Webinar Audio Proceedings)
-
Research to Practice Second Opinion: Investigators Provide Perspectives on the Current and Future Use of Novel Therapies for Non-Hodgkin Lymphoma | 2026 (Symposium Proceedings)
